查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1967687

硫酸軟骨素市場－全球產業規模、佔有率、趨勢、機會、預測：按原料、應用、區域和競爭對手分類，2021-2031年

Chondroitin Sulfate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球硫酸軟骨素市場預計將從 2025 年的 11.1 億美元成長到 2031 年的 13.5 億美元，複合年成長率為 3.32%。

硫酸軟骨素是一種硫酸化的Glico，是軟骨的基本結構成分。它廣泛用於藥物製劑和營養補充劑中，以維持關節活動度和組織健康。全球人口老化和骨關節炎發病率上升是推動該市場成長的主要因素，這加速了消費者向預防醫學和非侵入性關節管理方式的轉變。營養策略在促進身體健康方面的廣泛應用也支撐了這項需求。根據美國消費者保健產品協會 (CHPA) 2025 年的調查，83% 的受訪者使用營養補充品來維持健康，這為關節健康產品創造了非常有利的市場環境。

市場概覽
預測期 2027-2031
市場規模：2025年 11.1億美元
市場規模：2031年 13.5億美元
複合年成長率：2026-2031年 3.32%
成長最快的細分市場 動物飼料
最大的市場 亞太地區

儘管成長指標強勁，但由於高度依賴動物性原料，特別是鯊魚和牛軟骨，該市場仍面臨許多障礙。這種依賴使該行業易受供應鏈波動風險的影響，引發具有環保意識的消費者的道德抵制，並限制了在純素和植物來源食品盛行地區的市場擴張。此外，為防止動物性供應鏈中的詐欺行為而實施的嚴格品管，增加了生產的複雜性和成本，可能阻礙其廣泛進入市場。

市場促進因素

骨關節炎和關節疾病的日益普遍是全球硫酸軟骨素市場的主要驅動力。隨著全球軟骨退化性疾病加劇，迫切需要能夠抑制分解酶並促進蛋白聚醣合成的治療藥物。這項健康挑戰使硫酸軟骨素成為藥物和膳食補充劑管理通訊協定的基礎成分。根據2024年11月發表在《醫學前沿》（Frontiers in Medicine）上的一項研究“1990-2021年全球、區域和國家骨關節炎負擔”，全球骨關節炎患病率已達約6.069億例，形成了一個龐大的患者群體，他們依賴保守的關節炎治療。人們普遍依賴營養干預來維持身體健康，進一步推動了這項需求。根據責任營養委員會（CRN）於2024年10月發布的“2024年消費者調查”，75%的美國人使用膳食補充劑，這反映出一種持續的習慣，有利於關節健康產品類型的發展。

推動市場成長的第二個關鍵因素是寵物對獸用營養補充品和功能性寵物食品的需求不斷成長。隨著寵物飼主越來越像對待人類一樣對待他們的伴侶動物，透過飲食而非侵入性手術來治療貓狗髖關節發育不良的概念正日益受到關注。製造商們正積極響應這一需求，在高檔乾糧和零食中添加軟骨素，以主動解決整形外科問題，從而拓展了該成分在人類以外的應用。根據美國寵物用品協會 (APPA) 於 2024 年 8 月發布的《2024 年犬貓報告》的數據，自 2018 年以來，犬類維生素補充劑的使用量成長了近 50%，貓類成長了 60%。這一成長使原料生產商的收入來源更加多元化，並鞏固了軟骨素在高盈利的動物保健領域中的地位。

市場挑戰

全球硫酸軟骨素市場成長面臨的主要挑戰之一是高度依賴動物性原料，尤其是牛軟骨和鯊魚軟骨。這種依賴性使生產商容易受到漁業和肉類加工業波動的影響，導致原料供應不穩定，供應鏈不穩定。這種不穩定性阻礙了有效的生產計畫，使行業無法建立穩定的定價體系，並對長期可靠性和商業性擴充性負面影響。

此外，與動物性原料採購相關的倫理問題和嚴格的品質保證要求持續阻礙市場擴張。隨著消費者越來越重視永續性，植物來源的市場滲透也面臨挑戰。此外，為確保純度和防止動物性供應鏈中的詐欺行為而進行的強制性檢測，顯著增加了生產成本。這些增加的營運成本導致最終產品價格上漲，限制了價格敏感型消費者的購買力。責任營養委員會 (CRN) 2024 年的一項調查發現，27% 的非膳食補充劑使用者將成本列為主要障礙，這凸顯了這些複雜的供應鏈及其導致的價格上漲如何直接阻礙市場滲透。

市場趨勢

為了降低動物性成分相關的供應風險，製造商正加速採用純素和發酵生產方法，從根本上重塑全球硫酸軟骨素市場。製造商正迅速從傳統的鯊魚和牛軟骨萃取物轉向先進的微生物發酵技術，這些技術不僅純度更高、均一性更強，還能滿足消費者的倫理訴求。此技術轉變的基礎是非動物性替代品功效的顯著提升。根據《營養保健品商業評論》2025年4月刊題為「MyCondro：新時代的新名稱」的報告，藥物動力學研究證實，Resafre公司發酵法提取的硫酸軟骨素的生物利用度比標準牛來源高出45%，為高階關節健康配方樹立了新的標竿。

第二個主要趨勢是利用植物萃取物和膠原蛋白的協同配方日益普及。各大品牌不再局限於單一成分的軟骨素補充劑，而是致力於提供全面的關節活動解決方案。業內相關人員擴大將硫酸軟骨素等互補成分與未變性的II型膠原蛋白結合使用，以增強軟骨保護並降低成品中的有效劑量。這項策略旨在最大限度地提高治療效果，並在競爭激烈的市場中實現產品差異化。 BioIberica公司於2025年11月發布的《2025年全球供應端：Coravant n2與關節健康》報告中詳細介紹了一項新的臨床研究，該研究表明，該公司協同作用的膠原蛋白成分可將軟骨保護提高40%。這印證了市場對多方面關節健康系統（而非單一軟骨素療法）日益成長的需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球硫​​酸軟骨素市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依原料分類（牛來源、禽肉來源、合成材料、豬肉來源、鯊魚來源）
    • 按應用領域（營養補充品、個人護理/化妝品、動物飼料、藥品、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美硫酸軟骨素市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲硫酸軟骨素市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區硫酸軟骨素市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲硫酸軟骨素市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美硫酸軟骨素市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球硫​​酸軟骨素市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • TSI Group Ltd.
  • Qingdao Wan Toulmin Biological Products Co., Ltd
  • Hebei Sanxin Steel Structure Co Ltd
  • Bioiberica SAU
  • Sigma-Aldrich, Inc.
  • Sino Siam Biotechnique Company Limited
  • Bio-gen Extracts Private Limited
  • Zpd A/S
  • SEIKAGAKU CORPORATION
  • BRF SA

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20627

The Global Chondroitin Sulfate Market is projected to expand from USD 1.11 Billion in 2025 to USD 1.35 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 3.32%. Chondroitin sulfate, a sulfated glycosaminoglycan, serves as a fundamental structural element of cartilage and is extensively used in pharmaceutical formulations and dietary supplements to maintain joint mobility and tissue integrity. The market is primarily propelled by an aging global population and the increasing incidence of osteoarthritis, which have accelerated a consumer shift toward preventative healthcare and non-invasive joint management. This demand is further supported by the widespread acceptance of nutritional strategies for physical well-being. As noted by the Consumer Healthcare Products Association in 2025, 83% of voters utilize dietary supplements to support their wellness needs, creating a highly favorable environment for joint health products.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.11 Billion
Market Size 2031USD 1.35 Billion
CAGR 2026-20313.32%
Fastest Growing SegmentAnimal Feed
Largest MarketAsia Pacific

Despite these positive growth indicators, the market faces a substantial obstacle due to its heavy dependence on animal-derived raw materials, particularly shark and bovine cartilage. This reliance exposes the industry to supply chain volatility and raises ethical objections among environmentally conscious consumers, limiting market reach in regions where vegan or plant-based preferences prevail. Additionally, the rigorous quality control necessary to prevent adulteration in animal-sourced supply chains increases manufacturing complexity and costs, which can hinder broader market accessibility.

Market Driver

The escalating prevalence of osteoarthritis and joint disorders stands as the primary factor driving the Global Chondroitin Sulfate Market. As degenerative cartilage conditions worsen globally, there is an urgent need for therapeutic agents that can inhibit degradative enzymes and stimulate proteoglycan synthesis. This health burden has established chondroitin sulfate as a cornerstone in pharmaceutical and nutraceutical management protocols. According to the study 'Global, regional, and national burdens of osteoarthritis from 1990 to 2021,' published in Frontiers in Medicine in November 2024, the global prevalence of osteoarthritis has reached approximately 606.9 million cases, creating a vast patient base reliant on joint preservation therapies. This demand is reinforced by a widespread reliance on nutritional interventions for physical wellness; the Council for Responsible Nutrition's '2024 Consumer Survey' from October 2024 indicates that 75% of Americans use dietary supplements, reflecting a consistent habit that benefits joint-health product categories.

A second critical driver expanding the market scope is the increasing demand for veterinary supplements and functional pet food. As pet owners continue to humanize their companions, there is a growing focus on managing feline and canine hip dysplasia through diet rather than invasive surgeries. Manufacturers are addressing this by fortifying premium kibble and treats with chondroitin to proactively handle orthopedic issues, extending the ingredient's application beyond human consumption. Data from the American Pet Products Association's '2024 Dog and Cat Report' in August 2024 shows that vitamin and supplement usage has increased by nearly 50% for dogs and 60% for cats since 2018. This surge diversifies revenue streams for ingredient producers, securing a strong position for chondroitin within the lucrative animal health sector.

Market Challenge

The significant reliance on animal-derived raw materials, particularly bovine and shark cartilage, presents a major challenge that restricts the growth of the global chondroitin sulfate market. This dependence ties manufacturers to the fluctuations of the fishing and meat processing industries, creating exposure to unpredictable raw material availability and supply chain volatility. Such instability hampers effective production planning and prevents the industry from establishing consistent pricing structures, which is detrimental to long-term reliability and commercial scalability.

Furthermore, the ethical implications and stringent quality assurance requirements associated with animal sourcing continue to impede market expansion. As consumers increasingly value sustainability, the sector struggles to penetrate demographics that prefer plant-based alternatives. Moreover, the mandatory testing required to ensure purity and prevent adulteration in animal-derived supply chains significantly raises manufacturing expenses. These increased operational costs lead to higher final product prices, limiting accessibility for price-sensitive consumers. According to the Council for Responsible Nutrition in 2024, 27% of non-users identified cost as a primary barrier to adopting supplements, highlighting how price inflation caused by these supply complexities directly curtails broader market penetration.

Market Trends

The Global Chondroitin Sulfate Market is being fundamentally reshaped by the accelerated adoption of vegan and fermentation-based production methods, driven by the need to mitigate supply chain risks linked to animal-derived sources. Manufacturers are rapidly transitioning from traditional shark and bovine cartilage extraction to advanced microbial fermentation technologies, which offer superior purity and consistency while addressing ethical consumer concerns. This technological shift is validated by significant improvements in efficacy among non-animal alternatives. According to Nutraceutical Business Review in April 2025, the 'MyCondro: a new name for a new era' report highlighted pharmacokinetic studies confirming that Gnosis by Lesaffre's fermentation-derived chondroitin sulfate demonstrated 45% higher bioavailability than standard bovine-derived ingredients, setting a new standard for premium joint health formulations.

The second major trend is the rise of synergistic formulations utilizing botanical extracts and collagen, as brands move beyond single-ingredient chondroitin supplements to offer comprehensive mobility solutions. Industry players are increasingly combining chondroitin sulfate with complementary ingredients like undenatured Type II collagen to enhance cartilage protection and enable lower effective dosages in finished products. This strategy aims to maximize therapeutic outcomes and differentiate products in a crowded market. As detailed by Bioiberica in November 2025 in the 'SupplySide Global 2025: Collavant n2 and joint health' update, a new clinical study revealed that their synergistic collagen ingredient resulted in a 40% improvement in cartilage preservation, underscoring the growing preference for multi-targeted joint health systems over standalone chondroitin therapies.

Key Market Players

  • TSI Group Ltd.
  • Qingdao Wan Toulmin Biological Products Co., Ltd
  • Hebei Sanxin Steel Structure Co Ltd
  • Bioiberica S.A.U.
  • Sigma-Aldrich, Inc.
  • Sino Siam Biotechnique Company Limited
  • Bio-gen Extracts Private Limited
  • Zpd A/S
  • SEIKAGAKU CORPORATION
  • BRF SA

Report Scope

In this report, the Global Chondroitin Sulfate Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chondroitin Sulfate Market, By Source

  • Bovine
  • Poultry
  • Synthetic
  • Swine
  • Shark

Chondroitin Sulfate Market, By Application

  • Nutraceuticals
  • Personal Care & Cosmetics
  • Animal Feed
  • Pharmaceuticals
  • Others

Chondroitin Sulfate Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chondroitin Sulfate Market.

Available Customizations:

Global Chondroitin Sulfate Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chondroitin Sulfate Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source (Bovine, Poultry, Synthetic, Swine, Shark)
    • 5.2.2. By Application (Nutraceuticals, Personal Care & Cosmetics, Animal Feed, Pharmaceuticals, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Chondroitin Sulfate Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Chondroitin Sulfate Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Source
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Chondroitin Sulfate Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Source
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Chondroitin Sulfate Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Source
        • 6.3.3.2.2. By Application

7. Europe Chondroitin Sulfate Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Chondroitin Sulfate Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Source
        • 7.3.1.2.2. By Application
    • 7.3.2. France Chondroitin Sulfate Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Source
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Chondroitin Sulfate Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Source
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Chondroitin Sulfate Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Source
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Chondroitin Sulfate Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Source
        • 7.3.5.2.2. By Application

8. Asia Pacific Chondroitin Sulfate Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Chondroitin Sulfate Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Source
        • 8.3.1.2.2. By Application
    • 8.3.2. India Chondroitin Sulfate Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Source
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Chondroitin Sulfate Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Source
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Chondroitin Sulfate Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Source
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Chondroitin Sulfate Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Source
        • 8.3.5.2.2. By Application

9. Middle East & Africa Chondroitin Sulfate Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Chondroitin Sulfate Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Source
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Chondroitin Sulfate Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Source
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Chondroitin Sulfate Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Source
        • 9.3.3.2.2. By Application

10. South America Chondroitin Sulfate Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Chondroitin Sulfate Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Chondroitin Sulfate Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Chondroitin Sulfate Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Chondroitin Sulfate Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. TSI Group Ltd.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Qingdao Wan Toulmin Biological Products Co., Ltd
  • 15.3. Hebei Sanxin Steel Structure Co Ltd
  • 15.4. Bioiberica S.A.U.
  • 15.5. Sigma-Aldrich, Inc.
  • 15.6. Sino Siam Biotechnique Company Limited
  • 15.7. Bio-gen Extracts Private Limited
  • 15.8. Zpd A/S
  • 15.9. SEIKAGAKU CORPORATION
  • 15.10. BRF SA

16. Strategic Recommendations

17. About Us & Disclaimer